Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplier Quality Assurance Requires Hands-On, Risk-Based Strategy

This article was originally published in The Silver Sheet

Executive Summary

CONTROLLING THE QUALITY OF SUPPLIED PARTS AND MATERIALS can be a daunting task for device manufacturers, particularly when dealing with numerous contractors and components. Industry consultants recommend a risk-based approach to managing supplier relationships, with the most intensive evaluation and monitoring reserved for suppliers of critical parts. FDA investigators indicate that many firms are not devoting adequate attention and resources to purchasing control and incoming product acceptance activities; their observations are borne out by a steady stream of supplier-related citations in warning letters over the past couple years

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036092

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel